Its silencing was shown to diminish APP processing (Teranishi et al., 2015) and may impact on the crosstalk between APP and mSOD1, which seems to contribute to ALS pathology (Rabinovich-Toidman et al., 2015). The gene discussed is APP; the disease is amyotrophic lateral sclerosis.